Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2013

May 8, 2013

5229_dirs_2013-05-08_dc8eec51-30ec-4fca-abd7-982ed11be386.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2409E

AstraZeneca PLC

08 May 2013

Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 7 May 2013, the interest of the following individuals, who are all persons discharging managerial responsibilities, in AstraZeneca PLC ordinary shares, changed as detailed below.  The change in interest relates to the vesting of awards made in May 2010 under the AstraZeneca Performance Share Plan, whereby, following the application of performance measures specified at the time of grant, the individuals listed have now become beneficially entitled to 47% of the shares originally awarded.  In accordance with the plan rules, any unvested part of the award has immediately and irrevocably lapsed.  In each case, sufficient vested shares were withheld to cover certain tax obligations arising on the vesting.  The interest of Lynn Tetrault is in the Company's American Depositary Shares (ADSs).  One ADS equals one ordinary share.

Name Shares awarded Shares vested Shares withheld Net shares received Market price on vesting
Mene Pangalos 26,214 12,320 5,791 6,529 3339.5p
Jeff Pott 24,903 11,704 5,575 6,129 3339.5p
David Smith 24,903 11,704 5,235 6,469 3339.5p
Lynn Tetrault 48,585 22,834 10,550 12,284 $51.62

A C N Kemp

Company Secretary

8 May 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUWORROVAVRAR